Prem PharmD - CVS Health Group President
| 0HRS Stock | 60.01 2.74 4.78% |
President
Prem PharmD is Group President of CVS Health Corp
| Age | 44 |
| Address | One CVS Drive, Woonsocket, RI, United States, 02895 |
| Phone | 401 765 1500 |
| Web | https://www.cvshealth.com |
CVS Health Management Efficiency
The company has return on total asset (ROA) of 0.0237 % which means that it generated a profit of $0.0237 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.067 %, meaning that it generated $0.067 on every $100 dollars invested by stockholders. CVS Health's management efficiency ratios could be used to measure how well CVS Health manages its routine affairs as well as how well it operates its assets and liabilities. At this time, CVS Health's Total Assets are comparatively stable compared to the past year. Non Current Assets Total is likely to gain to about 191 B in 2024, whereas Other Assets are likely to drop slightly above 5.4 B in 2024.Similar Executives
| Showing other executives | PRESIDENT Age | ||
| Jaeseung Lee | Samsung Electronics Co | 64 | |
| Jyotindra Thacker | Reliance Industries Ltd | N/A | |
| Kyungwhoon Cheun | Samsung Electronics Co | N/A | |
| Kandasamy Sethuraman | Reliance Industries Ltd | 77 | |
| TaeMoon Roh | Samsung Electronics Co | 56 | |
| Young Kong | Hyundai Motor | N/A | |
| Dhanraj Nathwani | Reliance Industries Ltd | N/A | |
| JungBae Lee | Samsung Electronics Co | 57 | |
| Jose Barcelo | Hyundai Motor | 59 | |
| Jaeseung Lee | Samsung Electronics Co | 64 | |
| Parul Sharma | Reliance Industries Ltd | N/A | |
| Youngcho Chi | Hyundai Motor | N/A | |
| Kyungwhoon Cheun | Samsung Electronics Co | N/A | |
| JungBae Lee | Samsung Electronics Co | 57 | |
| HarkKyu Park | Samsung Electronics Co | 60 | |
| TaeMoon Roh | Samsung Electronics Co | 56 | |
| HyunChong Kim | Samsung Electronics Co | N/A | |
| Michael Chiang | Hon Hai Precision | N/A | |
| Boshin Seo | Hyundai Motor | N/A | |
| HyunChong Kim | Samsung Electronics Co | N/A | |
| HarkKyu Park | Samsung Electronics Co | 60 | |
Management Performance
| Return On Equity | 0.067 | ||||
| Return On Asset | 0.0237 |
CVS Health Corp Leadership Team
Elected by the shareholders, the CVS Health's board of directors comprises two types of representatives: CVS Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of CVS. The board's role is to monitor CVS Health's management team and ensure that shareholders' interests are well served. CVS Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, CVS Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Thomas Moriarty, Chief VP | ||
| Katerina Guerraz, Chief VP | ||
| Sreekanth MD, Executive Officer | ||
| Shawn Guertin, Ex CFO | ||
| Vijay Patel, Senior CoFounder | ||
| James Clark, Controller VP | ||
| David Falkowski, Executive Officer | ||
| Prem PharmD, Group President | ||
| FACEP MD, VP Officer | ||
| Laurence McGrath, Senior Relations | ||
| Norman Greve, Chief Officer | ||
| Laurie Havanec, Executive Officer | ||
| David CEBS, Executive Caremark | ||
| Tilak Mandadi, Data, Digital | ||
| Thomas Cowhey, Executive CFO | ||
| Gustavo Giraldo, Head Benefits | ||
| Larry McGrath, Sr Relations | ||
| Samrat Esq, Chief VP | ||
| Alan MD, Ex Services | ||
| Heidi Capozzi, Executive Officer | ||
| Sheryl Burke, Chief Responsibility | ||
| MPP MD, Senior President | ||
| Karen Lynch, CEO President | ||
| Michelle Peluso, Executive Officer |
CVS Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is CVS Health a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.067 | ||||
| Return On Asset | 0.0237 | ||||
| Profit Margin | 0.01 % | ||||
| Operating Margin | 0.02 % | ||||
| Current Valuation | 145.26 B | ||||
| Shares Outstanding | 1.02 B | ||||
| Shares Owned By Insiders | 0.11 % | ||||
| Shares Owned By Institutions | 82.91 % | ||||
| Price To Sales | 0.20 X | ||||
| Revenue | 357.78 B |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for CVS Stock Analysis
When running CVS Health's price analysis, check to measure CVS Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CVS Health is operating at the current time. Most of CVS Health's value examination focuses on studying past and present price action to predict the probability of CVS Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CVS Health's price. Additionally, you may evaluate how the addition of CVS Health to your portfolios can decrease your overall portfolio volatility.